Meeting Coverage:

American Society of Cataract and Refractive Surgery Meeting

ASCRS: 2015

What's New in the Treatment of Bacterial Keratitis?

Show Description +

Moderator Casey Claypool, OD, of Empire Eye in Spokane, Washington, discusses new trends in the treatment of bacterial keratitis with Francis Mah, MD, of Scripps Clinic Torrey Pines in La Jolla, California. The prevalence of methicillin-resistant Staphylococcus aureus is increasing, and it is a very difficult pathogen to eradicate. Three medications, FDA approved for systemic use, can be compounded for ocular treatment and are helpful in these cases.

Posted: 4/16/2015

Keywords:

Keratitis

Up Next


Cross-Linking: Use in Refractive Surgery

Arthur Cummings, MD, Michael Mrochen, PhD

The Ethics of Femtosecond Laser Cataract Surgery

Kendall Donaldson, MD, Mark Kontos, MD

The Refractive Surgery Alliance

Guy M. Kezirian, MD, Jay S. Pepose, MD, PhD

First-ever Iris Prosthesis Skills Lab at ASCRS

Michael Snyder MD, Steven Vold, MD

Corneal Topographic Astigmatism and Total Corneal Power

Noel Alpins, FRANZCO, FRCOphth, Steven Vold, MD

Advanced Ocular Modeling for IOL Power Calculations

Arthur Cummings, MD, Michael Mrochen, PhD

Preview to the 2015 Cataract and Refractive Surgery Meeting in San Diego

Cynthia Matossian, MD, Damien Goldberg, MD, George O. Waring IV, MD, James Katz, MD, Robert J. Weinstock, MD, William Trattler, MD

What's New in the Treatment of Bacterial Keratitis?

Moderator Casey Claypool, OD, of Empire Eye in Spokane, Washington, discusses new trends in the treatment of bacterial keratitis with Francis Mah, MD, of Scripps Clinic Torrey Pines in La Jolla, California. The prevalence of methicillin-resistant Staphylococcus aureus is increasing, and it is a very difficult pathogen to eradicate. Three medications, FDA approved for systemic use, can be compounded for ocular treatment and are helpful in these cases.

Posted: 4/16/2015

Keywords:

Keratitis

Please log in to leave a comment.